SEARCH

SEARCH BY CITATION

References

  • Blant, J.M. & Altman, D.G. (1986) Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet, 1, 307310.
  • Böck, M., De Haan, J., Beck, K.H., Gutensohn, K., Hertfelder, H.J., Karger, R., Heim, M.U. & Beeser, H. (1999) Standardization of the PFA-100® platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking and oral contraceptives. British Journal of Haematology, 106, 898904.
  • Brezinski, D.A., Tofler, G.H., Muller, J.E., Pohjola-Sintonen, S., Willich, S.N., Schafer, A.I., Czeisler, C.A. & Williams, G.H. (1988) Morning increase in platelet aggregability. Circulation, 78, 3540.
  • Cariappa, R., Wilhite, T.R., Parvin, C.A. & Luchtman-Jones, L. (2003) Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems. Journal of Pediatric Hematology/Oncology, 25, 474479.
  • Cattaneo, M., Federici, A.B., Lecchi, A., Lombardi, R., Stabile, F. & Bucciarelli, P. (1999) Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thrombosis and Haemostasis, 82, 3539.
  • Chakroun, T., Gerotziafas, G., Robert, F., Lecrubier, C., Samama, M.M., Hatmi, M. & Elalamy, I. (2004) In vitro aspirin resistance detected by PFA-100TM closure time: pivotal role of plasma von Willebrand factor. British Journal of Haematology, 124, 8085.
  • Dalby, M.C., Davidson, S.J., Burman, J.F. & Davies, S.W. (2000) Diurnal variation in platelet aggregation with the PFA-100 platelet function analyser. Platelets, 11, 320324.
  • Dean, J.A., Blanchette, V.S., Carcao, M.D., Stain, A.M., Sparling, C.R., Siekmann, J., Turecek, P.L., Lillicrap, D. & Rand, M.L. (2000) Von Willebrand disease in a pediatric-based population – comparison of type 1 diagnostic criteria and use of the PFA-100® and a von Willebrand factor/collagen-binding assay. Thrombosis and Haemostasis, 84, 401409.
  • Favarolo, E.J. (2002) Clinical application of the PFA-100®. Current Opinion in Hematology, 9, 407415.
  • Francis, J., Francis, D., Larson, L., Helms, E. & Garcia, M. (1999) Can the platelet function analyzer (PFA®)-100 test substitute for the template bleeding time in routine clinical practice? Platelets, 10, 132136.
  • Fressinaud, E., Veyradier, A., Truchaud, F., Martin, I., Boyer-Neumann, C., Troussaert, M. & Meyer, D. (1998) Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood, 91, 13251331.
  • Gum, P.A., Kottke-Marchant, K., Poggio, E.D., Gurm, H., Welsh, P.A., Brooks, L., Sapp, S.K. & Topol, E.J. (2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. American Journal of Cardiology, 88, 230235.
  • Harrison, P. (2004) In vitro measurement of high-shear platelet adhesion and aggregation by the PFA-100®. Methods in Molecular Biology, 272, 215223.
  • Harrison, P., Robinson, M.S.C., Mackie, I.J., Joseph, J., McDonald, S.J., Liesner, R., Savidge, G.F., Pasi, J. & Machin, S.J. (1999) Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis. Blood Coagulation and Fibrinolysis, 10, 2531.
  • Harrison, P., Robinson, M., Liesner, R., Khair, K., Cohen, H., Mackie, I. & Machin, S. (2002) The PFA-100®: a potential rapid screening tool for the assessment of platelet dysfunction. Clinical and Laboratory Haematology, 24, 225232.
  • Harrison, P., Segal, H., Furtado, C., Verjee, S., Sukhu, K. & Murphy, M.F. (2004) High incidence of defective high-shear platelet function among platelet donors. Transfusion, 44, 764770.
  • Haus, E., Cusulos, M., Sackett-Lundeen, L. & Swoyer, J. (1990) Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects. Chronobiology International, 7, 203216.
  • Heilmann, E.J., Kundu, S.K., Sio, R., Garcia, C., Gomez, R. & Christie, D.J. (1997) Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100TM system. Thrombosis Research, 87, 15964.
  • Jilma, B. (2001) platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. Journal of Laboratory and Clinical Medicine, 138, 152163.
  • Jilma-Stohlawetz, P., Hergovich, N., Homoncik, M., Dzirlo, L., Horvath, M., Janisiw, M., Panzer, S. & Jilma, B. (2001) Impaired platelet function among donors. Thrombosis and Haemostasis, 86, 880886.
  • Jovicic, A. & Mandic, S. (1991) Circadian variation of platelet aggregability and fibrinolytic activity in healthy subjects. Thrombosis Research, 62, 6574.
  • Kundu, S.K., Heilmann, E.J., Sio, R., Garcia, C., Davidson, R.M. & Ostgaard, R.A. (1995) Description of an in vitro platelet function analyzer – PFA-100TM. Seminars in Thrombosis and Hemostasis, 21(Suppl. 2), 106112.
  • Kundu, S.K., Heilmann, E.J., Sio, R., Garcia, C. & Ostgaard, A. (1996) Characterization of an in vitro platelet function analyzer, PFA-100TM. Clinical and Applied Thrombosis/Hemostasis, 2, 241249.
  • Lippi, G., Franchini, M., Brocco, G. & Manzato, F. (2001) Influence of the ABO blood type on the platelet function analyzer PFA-100. Thrombosis and Haemostasis, 85, 369370.
  • Malyszko, J., Urano, T., Knofler, R., Taminato, A., Takada, Y. & Takada, A. (1994) Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes. Thrombosis Research, 75, 569576.
  • Mammen, E.F., Alshameeri, R.S. & Comp, P.C. (1995) Preliminary data from a field trial of the PFA-100TM system. Seminars in Thrombosis and Hemostasis, 21(Suppl. 2), 113121.
  • Mammen, E.F., Comp, P.C., Gosselin, R., Greenberg, C., Hoots, W.K., Kessler, C.M., Larkin, E.C., Liles, D. & Nugent, D.J. (1998) PFA-100TM system: a new method for assessment of platelet dysfunction. Seminars in Thrombosis and Hemostasis, 24, 195202.
  • McKee, S.A., Sane, D.C. & Deliargyris, N. (2002) Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. Thrombosis and Haemostasis, 88, 711715.
  • Miller, M.E., Thorpe, S.L. & Dores, G.M. (1995) Influence of hormones on platelet intracellular calcium. Thrombosis Research, 77, 515530.
  • Moeller, A., Weippert-Kretschmer, M., Prinz, H. & Kretschmer, V. (2001) Influence of ABO blood groups on primary hemostasis. Transfusion, 41, 5660.
  • Norris, L.A., Devitt, M. & Bonnar, J. (1996) The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users. Thrombosis Research, 81, 407417.
  • Posan, E., McBane, R.D., Grill, D.E., Motsko, C.L. & Nichols, W.L. (2003) Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thrombosis and Haemostasis, 90, 483490.
  • Quiroga, T., Goycoolea, M., Munoz, B., Morales, M., Aranda, E., Panes, O., Pereira, J. & Mezzano, D. (2004) Template bleeding time and PFA-100® have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. Journal of Thrombosis and Haemostasis, 2, 892898.
  • Rahmann, K. & Billington, D. (2000) dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. Journal of Nutrition, 130, 26622665.
  • Saleh, A.A., Ginsburg, K.A., Duchon, T.A., Dorey, L.G., Hirata, J., Alshameeri, R.S., Dombrowski, M.P. & Mammen, E.F. (1995) Hormonal contraception and platelet function. Thrombosis Research, 78, 363367.
  • Schlammadinger, A., Kerenyi, A., Muszbek, L. & Boda, Z. (2000) Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease. Thrombosis and Haemostasis, 84, 8892.
  • Sestito, A., Sciahbasi, A., Landolfi, R., Maseri, A., Lanza, G.A. & Andreotti, F. (1999) A simple assay for platelet-mediated hemostasis in flowing whole blood (PFA-100): reproducibility and effects of sex and age. Cardiologica, 44, 661665.
  • Tofler, H., Brezinski, D., Schafer, A.I., Czeisler, C.A., Rutherford, J.D., Willich, S.N., Gleason, R.E., Williams, G.H. & Muller, J.E. (1987) Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. New England Journal of Medicine, 316, 15141518.
  • Wuillemin, W.A., Gasser, K.M., Zeerleder, S.S. & Lämmle, B. (2002) Evaluation of a platelet function analyser (PFA-100®) in patients with a bleeding tendency. Swiss Medical Weekly, 132, 443448.